To access this content, you must be a member. Visit the Plans page for details.
SocGen in exclusive talks to sell most of Lyxor to Amundi
Societe Generale is in advanced talks to sell most of Lyxor to Paris-based Amundi for €825 million ($979 million). The [Read More]